BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2262 related articles for article (PubMed ID: 21371747)

  • 1. Alzheimer's disease.
    Ballard C; Gauthier S; Corbett A; Brayne C; Aarsland D; Jones E
    Lancet; 2011 Mar; 377(9770):1019-31. PubMed ID: 21371747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
    Thal DR; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond diagnosis: what biomarkers are teaching us about the "bio"logy of Alzheimer disease.
    Rabinovici GD; Roberson ED
    Ann Neurol; 2010 Mar; 67(3):283-5. PubMed ID: 20373338
    [No Abstract]   [Full Text] [Related]  

  • 4. Alzheimer's disease.
    Scheltens P; Blennow K; Breteler MM; de Strooper B; Frisoni GB; Salloway S; Van der Flier WM
    Lancet; 2016 Jul; 388(10043):505-17. PubMed ID: 26921134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.
    Mondragón-Rodríguez S; Basurto-Islas G; Lee HG; Perry G; Zhu X; Castellani RJ; Smith MA
    Expert Rev Neurother; 2010 May; 10(5):683-91. PubMed ID: 20420489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging as a strategy for premortem diagnosis and staging of tauopathies.
    Kim S; Jensen JR; Cisek K; Funk KE; Naphade S; Schafer K; Kuret J
    Curr Alzheimer Res; 2010 May; 7(3):230-4. PubMed ID: 20088805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current understanding of Alzheimer's disease diagnosis and treatment.
    Weller J; Budson A
    F1000Res; 2018; 7():. PubMed ID: 30135715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.
    Ashrafian H; Zadeh EH; Khan RH
    Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E genotype in senile dementia with tangles differs from Alzheimer's disease.
    Tolnay M; Villoz N; Probst A; Miserez AR
    Neuropathol Appl Neurobiol; 2003 Feb; 29(1):80-4. PubMed ID: 12581343
    [No Abstract]   [Full Text] [Related]  

  • 10. Alzheimer disease.
    Castellani RJ; Rolston RK; Smith MA
    Dis Mon; 2010 Sep; 56(9):484-546. PubMed ID: 20831921
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological aspects and anti-amyloid strategy for Alzheimer's dementia.
    Liščić RM
    Arh Hig Rada Toksikol; 2013 Dec; 64(4):603-8. PubMed ID: 24384767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alzheimer's disease: cellular and molecular aspects].
    Octave JN; Pierrot N
    Bull Acad Natl Med; 2008 Feb; 192(2):323-31; discussion 331-2. PubMed ID: 18819686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.
    Armstrong RA
    Folia Neuropathol; 2009; 47(4):289-99. PubMed ID: 20054780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition.
    Tan CH; Fan CC; Mormino EC; Sugrue LP; Broce IJ; Hess CP; Dillon WP; Bonham LW; Yokoyama JS; Karch CM; Brewer JB; Rabinovici GD; Miller BL; Schellenberg GD; Kauppi K; Feldman HA; Holland D; McEvoy LK; Hyman BT; Bennett DA; Andreassen OA; Dale AM; Desikan RS;
    Acta Neuropathol; 2018 Jan; 135(1):85-93. PubMed ID: 29177679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular imaging of Alzheimer's disease].
    Albert A; Borbély K
    Orv Hetil; 2019 Aug; 160(33):1289-1295. PubMed ID: 31401858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of Tau Load in Alzheimer's Disease Clinical Trials Using Positron Emission Tomography.
    Timmers T; van Berckel BNM; Lammertsma AA; Ossenkoppele R
    Methods Mol Biol; 2018; 1750():221-229. PubMed ID: 29512076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for improving the postmortem neuropathological diagnosis of Alzheimer's disease.
    Trojanowski JQ; Clark CM; Schmidt ML; Arnold SE; Lee VM
    Neurobiol Aging; 1997; 18(4 Suppl):S75-9. PubMed ID: 9330990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease.
    Cohen AD; Landau SM; Snitz BE; Klunk WE; Blennow K; Zetterberg H
    Mol Cell Neurosci; 2019 Jun; 97():3-17. PubMed ID: 30537535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease.
    Madav Y; Wairkar S; Prabhakar B
    Brain Res Bull; 2019 Mar; 146():171-184. PubMed ID: 30634016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibrillary tangles and beta-amyloid deposits in Alzheimer's disease.
    Goedert M; Sisodia SS; Price DL
    Curr Opin Neurobiol; 1991 Oct; 1(3):441-7. PubMed ID: 1821689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 114.